NITRASE-color-horizontal.jpg
Nitrase Therapeutics Expands Pipeline to Include Oncology Programs and Adds Seasoned Cancer Experts to Scientific Advisory Board
02 juin 2022 08h00 HE | Nitrase Therapeutics
BRISBANE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a...
NITRASE-color-horizontal.jpg
Nitrase Therapeutics Receives New Grant from The Michael J. Fox Foundation for Parkinson’s Research
05 avr. 2022 08h00 HE | Nitrase Therapeutics
BRISBANE, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a...
NITRASE-color-horizontal.jpg
Nitrase Therapeutics Announces Major Discovery In Parkinson’s Disease Presented At The AD/PD International Conference
18 mars 2022 08h00 HE | Nitrase Therapeutics
-Company Identifies Potential New Biomarker And Diagnostic For Parkinson’s Disease- SAN FRANCISCO, March 18, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc. (formerly Nitrome Biosciences), a...
NITRASE-color-horizontal.jpg
Nitrome Biosciences Appoints Pierre Beaurang, Ph.D., as Chief Executive Officer, Expands Series A to $45M, and Changes Company Name to Nitrase Therapeutics
02 nov. 2021 08h00 HE | Nitrase Therapeutics
SAN FRANCISCO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc. (formerly Nitrome Biosciences), a biopharmaceutical company deploying its unique NITROME platform to unlock the...
Nitrome_logo_2020.png
Nitrome Biosciences Announces Formation of Scientific Advisory Board and Appointment of Former AbbVie Executive James Summers, Ph.D. to SAB Chairperson
12 nov. 2020 16h00 HE | Nitrome Biosciences
SAN FRANCISCO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around its newly discovered class of enzymes to...
Nitrome_logo_2020.png
Nitrome Biosciences Appoints Industry Veteran Perry Karsen as Executive Chairman of the Board of Directors
13 oct. 2020 08h00 HE | Nitrome Biosciences
SAN FRANCISCO, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around its newly discovered class of enzymes to...